Sutro Biopharma, Inc. (STRO)
USD 1.85
(-11.48%)
USD 1.85
(-11.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -111.61 Million | 3.54 Million | -81.67 Million | -67.8 Million | -65.02 Million | 12.68 Million |
| Net Income | -106.79 Million | -119.2 Million | -105.53 Million | -32.12 Million | -55.74 Million | -35.31 Million |
| Depreciation & Amortization | 6.81 Million | 5.69 Million | 4.84 Million | 4.29 Million | 4.77 Million | 4.53 Million |
| Deferred income taxes | 24.14 Million | - | 7.23 Million | -41 Million | -1.29 Million | -1.5 Million |
| Stock-based compensation | 24.9 Million | 26.3 Million | 23.24 Million | 11.91 Million | 10.31 Million | 2.87 Million |
| Change in working capital | -34.37 Million | 104.4 Million | -17.62 Million | -11.48 Million | -23.26 Million | 42.6 Million |
| Other non-cash items | -26.31 Million | -13.64 Million | 6.15 Million | 606 Thousand | 193 Thousand | -517 Thousand |
| Investing Cash Flow | -3.92 Million | -35.02 Million | -97.31 Million | 604 Thousand | -51.13 Million | -80.19 Million |
| Investments in PPE | -4.31 Million | -7.85 Million | -15.32 Million | -7.12 Million | -3.48 Million | -1.55 Million |
| Acquisitions | -391 Thousand | 28.73 Million | - | - | 47.65 Million | - |
| Investment purchases | -460.3 Million | -216.67 Million | -248.72 Million | -130.74 Million | -196.22 Million | -81.46 Million |
| Sales/Maturities of investments | 460.69 Million | 189.49 Million | 166.72 Million | 138.38 Million | 148.57 Million | 2.75 Million |
| Other Investing Activities | 391 Thousand | -28.73 Million | 9000.00 | 89 Thousand | -47.65 Million | 80 Thousand |
| Financing Cash Flow | 137.55 Million | 48.31 Million | 3.25 Million | 269.24 Million | -4.18 Million | 170.78 Million |
| Debt repayment | -12.5 Million | -9.37 Million | - | -10 Million | -5 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -490 Thousand | -463 Thousand | -7000.00 | -314 Thousand | -297 Thousand | - |
| Common Stock Issuance | 14.33 Million | 56.27 Million | 4.25 Million | 251.41 Million | 180 Thousand | 84.43 Million |
| Other Financing Activities | 150.54 Million | 1.88 Million | -987 Thousand | 28.14 Million | 933 Thousand | 86.34 Million |
| Accounts receivables | -28.95 Million | 5.34 Million | -6.89 Million | 739 Thousand | -3.8 Million | -865 Thousand |
| Accounts payables | 4.81 Million | -1.22 Million | 6.43 Million | -947 Thousand | 2.25 Million | 209 Thousand |
| Inventory | - | - | -4.54 Million | -58 Thousand | -1.25 Million | -1.66 Million |
| Other working capital | -10.23 Million | 100.28 Million | -12.61 Million | -11.22 Million | -20.45 Million | 44.93 Million |
| Cash at beginning of period | 47.25 Million | 31.28 Million | 207.02 Million | 4.97 Million | 125.31 Million | 22.03 Million |
| Cash at end of period | 69.26 Million | 48.12 Million | 31.28 Million | 207.02 Million | 4.97 Million | 125.31 Million |
| Capital Expenditure | -4.31 Million | -7.85 Million | -15.32 Million | -7.12 Million | -3.48 Million | -1.55 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 22.01 Million | 16.84 Million | -175.73 Million | 202.04 Million | -120.33 Million | 103.27 Million |
| Free Cash Flow | -115.93 Million | -4.3 Million | -97 Million | -74.93 Million | -68.5 Million | 11.12 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -48.01 Million | -58.21 Million | 31.06 Million | -106.79 Million | -49.28 Million | -38.52 Million |
| Depreciation & Amortization | 1.79 Million | 1.76 Million | 1.73 Million | 6.81 Million | 1.73 Million | 1.73 Million |
| Deferred income taxes | - | - | -25.07 Million | 24.14 Million | -3.08 Million | -10.16 Million |
| Stock-based compensation | 6.15 Million | 6.06 Million | 6.22 Million | 24.9 Million | 6 Million | 6.66 Million |
| Change in working capital | 48.37 Million | -16.61 Million | -21.58 Million | -34.37 Million | 3.74 Million | 7.87 Million |
| Other non-cash items | -12.06 Million | 8.96 Million | 21.71 Million | -26.31 Million | 7.38 Million | 1.22 Million |
| Investing Cash Flow | -80.37 Million | 64.1 Million | -23.51 Million | -3.92 Million | -114.01 Million | 66.15 Million |
| Investments in PPE | -756 Thousand | -446 Thousand | -1.44 Million | -4.31 Million | -328 Thousand | -1.6 Million |
| Acquisitions | - | - | 22.07 Million | -391 Thousand | 113.69 Million | -67.76 Million |
| Investment purchases | -157.33 Million | -135 Million | -80.57 Million | -460.3 Million | -238.36 Million | -88.59 Million |
| Sales/Maturities of investments | 77.71 Million | 199.55 Million | 58.5 Million | 460.69 Million | 124.67 Million | 156.35 Million |
| Other Investing Activities | -79.61 Million | 64.55 Million | -22.07 Million | 391 Thousand | -113.69 Million | 67.76 Million |
| Financing Cash Flow | 96.49 Million | -3.42 Million | -3.12 Million | 137.55 Million | -5.74 Million | 137.66 Million |
| Debt repayment | - | -4.08 Million | -3.12 Million | -12.5 Million | -3.12 Million | -3.12 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -37 Thousand | -374 Thousand | 490 Thousand | -490 Thousand | -33 Thousand | -6000.00 |
| Common Stock Issuance | 96.52 Million | 1.02 Million | -954 Thousand | 14.33 Million | 954 Thousand | 1.04 Million |
| Other Financing Activities | -37 Thousand | -374 Thousand | -136.2 Million | 150.54 Million | -2.58 Million | 140.79 Million |
| Accounts receivables | 24.35 Million | 4.77 Million | -19.45 Million | -28.95 Million | -6.62 Million | -126 Thousand |
| Accounts payables | -1.39 Million | -1.89 Million | 4.05 Million | 4.81 Million | 1.41 Million | -857 Thousand |
| Inventory | - | - | -12.89 Million | - | 2.87 Million | 10.02 Million |
| Other working capital | 25.41 Million | -19.49 Million | -6.18 Million | -10.23 Million | 6.08 Million | -1.16 Million |
| Cash at beginning of period | 65.21 Million | 69.26 Million | 81.83 Million | 47.25 Million | 235.96 Million | 63.34 Million |
| Cash at end of period | 90.78 Million | 65.21 Million | 69.26 Million | 69.26 Million | 82.7 Million | 235.96 Million |
| Capital Expenditure | -756 Thousand | -446 Thousand | -1.44 Million | -4.31 Million | -328 Thousand | -1.6 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 25.57 Million | -4.05 Million | -12.56 Million | 22.01 Million | -153.26 Million | 172.62 Million |
| Free Cash Flow | 8.69 Million | -65.18 Million | 12.63 Million | -115.93 Million | -33.83 Million | -32.79 Million |
ALUA
CHOICEIN
PUSOF
301011
9039
1259